Cargando…

Dicer Enhances Bevacizumab-Related Inhibition of Hepatocellular Carcinoma via Blocking the Vascular Endothelial Growth Factor Pathway

PURPOSE: Vascular endothelial growth factor (VEGF) family members contribute greatly to the development and angiogenesis of hypervascular hepatocellular carcinoma (HCC). We have previously shown that Dicer inhibited HCC growth. In this study, we aimed to determine the relationship between Dicer and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Cuiju, Lv, Yalei, Sha, Ziyue, Zhang, Jingjing, Wu, Jianhua, Qi, Yixin, Guo, Zhanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8721026/ https://www.ncbi.nlm.nih.gov/pubmed/35004391 http://dx.doi.org/10.2147/JHC.S327258

Ejemplares similares

Dicer Suppresses Hepatocellular Carcinoma via Interleukin-8 Pathway
por: Han, Xin, et al.
Publicado: (2023)

Prognostic significance of Dicer expression in hepatocellular carcinoma
por: ZHANG, LI, et al.
Publicado: (2016)

Bevacizumab, an anti-vascular endothelial growth factor antibody, inhibits osteoarthritis
por: Nagai, Toshihiro, et al.
Publicado: (2014)

Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
por: Wu, Jianhua, et al.
Publicado: (2021)

Endometriosis-targeted MRI imaging using bevacizumab-modified nanoparticles aimed at vascular endothelial growth factor
por: Zhang, Qi, et al.
Publicado: (2023)

Bevacizumab neutralizes the protective effect of vascular endothelial growth factor on retinal ganglion cells
por: Brar, Vikram S., et al.
Publicado: (2010)

Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
por: Wang, Donghyun, et al.
Publicado: (2014)

Are anti-PD-1-associated immune related adverse events a harbinger of favorable clinical prognosis in patients with gastric cancer?
por: Zhang, Xiaoyun, et al.
Publicado: (2022)

Influence of vascular endothelial growth factor inhibition on simple renal cysts in patients receiving bevacizumab-based chemotherapy
por: Grenader, Tal, et al.
Publicado: (2015)

Effect of Intravitreal Bevacizumab on Vascular Endothelial Growth Factor Expression in Patients with Proliferative Diabetic Retinopathy
por: Chung, Eun Jee, et al.
Publicado: (2011)

Concentration of Vascular Endothelial Growth Factor After Intracameral Bevacizumab Injection in Eyes With Neovascular Glaucoma
por: Lim, Tae Hoon, et al.
Publicado: (2009)

Intravitreal Bevacizumab as Anti-Vascular Endothelial Growth Factor in the Management of Complications of Proliferative Diabetic Retinopathy
por: Fernando Arevalo, J.
Publicado: (2013)

Effects of anti-vascular endothelial growth factor monoclonal antibody (bevacizumab) on lens epithelial cells
por: Jun, Jong Hwa, et al.
Publicado: (2016)

miR-502 medaited histone methyltransferase SET8 expression is associated with outcome of esophageal squamous cell carcinoma
por: Wang, Cuiju, et al.
Publicado: (2016)

Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4
por: Hartmann, Petra, et al.
Publicado: (2016)

Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
por: Papadopoulos, Nicholas, et al.
Publicado: (2012)

Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer
por: Weickhardt, A J, et al.
Publicado: (2015)

Corrigendum: Endothelial Dicer promotes atherosclerosis and vascular inflammation by miRNA-103-mediated suppression of KLF4
por: Hartmann, Petra, et al.
Publicado: (2016)

Vascular endothelial growth factor-A is an Immunohistochemical biomarker for the efficacy of bevacizumab-containing chemotherapy for duodenal and jejunal adenocarcinoma
por: Amano, Takahiro, et al.
Publicado: (2021)

Role of Bevacizumab on Vascular Endothelial Growth Factor in Apolipoprotein E Deficient Mice after Traumatic Brain Injury
por: Genovese, Tiziana, et al.
Publicado: (2022)

Bevacizumab, a vascular endothelial growth factor inhibitor, promotes orthodontic tooth movement in an experimental rat model
por: Abuohashish, Hatem, et al.
Publicado: (2023)

MAZ51 Blocks the Tumor Growth of Prostate Cancer by Inhibiting Vascular Endothelial Growth Factor Receptor 3
por: Yamamura, Aya, et al.
Publicado: (2021)

Linomide blocks angiogenesis by breast carcinoma vascular endothelial growth factor transfectants.
por: Ziche, M., et al.
Publicado: (1998)

Intravenous administration of anti-vascular endothelial growth factor humanized monoclonal antibody bevacizumab improves articular cartilage repair
por: Nagai, Toshihiro, et al.
Publicado: (2010)

Detection of vascular endothelial growth factor in colon cancer xenografts using bevacizumab based near infrared fluorophore conjugate
por: Paudyal, Bishnuhari, et al.
Publicado: (2014)

Topical versus subconjunctival anti-vascular endothelial growth factor therapy (Bevacizumab, Ranibizumab and Aflibercept) for treatment of corneal neovascularization
por: Al-Debasi, Tariq, et al.
Publicado: (2017)

Identification of sequence polymorphism in the D-Loop region of mitochondrial DNA as a risk factor for hepatocellular carcinoma with distinct etiology
por: Zhang, Ruixing, et al.
Publicado: (2010)

Impact of DICER1 and DROSHA on the Angiogenic Capacity of Human Endothelial Cells
por: Braun, Heike, et al.
Publicado: (2021)

Survival benefit and safety of the combinations of FOLFOXIRI ± bevacizumab versus the combinations of FOLFIRI ± bevacizumab as first-line treatment for unresectable metastatic colorectal cancer: a meta-analysis
por: Xu, Wei, et al.
Publicado: (2016)

Bevacizumab‐enhanced antitumor effect of 5‐fluorouracil via upregulation of thymidine phosphorylase through vascular endothelial growth factor A/vascular endothelial growth factor receptor 2‐specificity protein 1 pathway
por: Liu, Wenyue, et al.
Publicado: (2018)

Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma
por: Kim, Mi Na, et al.
Publicado: (2016)

A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy
por: Van Geest, Rob J, et al.
Publicado: (2012)

DICER1 Syndrome: DICER1 Mutations in Rare Cancers
por: Robertson, Jake C., et al.
Publicado: (2018)

Dicing the Disease with Dicer: The Implications of Dicer Ribonuclease in Human Pathologies
por: Theotoki, Eleni I., et al.
Publicado: (2020)

Anti‐bevacizumab idiotype antibody vaccination is effective in inducing vascular endothelial growth factor‐binding response, impairing tumor outgrowth
por: Sanches, Jéssica de Souza, et al.
Publicado: (2016)

Anti-Vascular Endothelial Growth Factor (Bevacizumab) Therapy Reduces Hypertrophic Scar Formation in a Rabbit Ear Wounding Model
por: Kwak, Do Hoon, et al.
Publicado: (2016)

CHANGES IN PLASMA VASCULAR ENDOTHELIAL GROWTH FACTOR LEVEL AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB, AFLIBERCEPT, OR RANIBIZUMAB FOR DIABETIC MACULAR EDEMA
por: Hirano, Takao, et al.
Publicado: (2018)

The role of bevacizumab in targeted vascular endothelial growth factor therapy for epithelial ovarian cancer: an updated systematic review and meta-analysis
por: Ruan, Guanyu, et al.
Publicado: (2018)

Serum vascular endothelial growth factor changes and safety after topical anti‐human VEGF antibody bevacizumab in healthy dogs
por: Muellerleile, Lisa‐Marie, et al.
Publicado: (2019)

Single nucleotide polymorphisms in the mitochondrial displacement loop and age at onset of non-Hodgkin lymphoma
por: Fan, Haiyan, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_3b10av7n0l4audcn5so8lkj3uk